Barely Significant
← all excerpts

Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?

Cancers (Basel) · 2019 · PMC6826876 · PMID 31614884

1
hedged sentence
closest p
boldest claim

The sentences

a slight trendno p-value reported
In contrast, CRT ( n = 241) seemed to provide only a slight trend towards an OS advantage in R1-resected pts, emerging as a positive difference in median values of 3.5 months, as well as non-significant HR of 0.72 and 2-y and 5-y rates (30% vs. 19% with observation, and 18% vs. 8%, respectively).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.